Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway

Overview of attention for article published in Stem Cell Research & Therapy, June 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway https://t.co/bLUxStEXeP #uterinecancer #oncology https://t.co/Q6NNydAAdp

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.